Diagnostic performance of Ultrasound-Guided Attenuation Parameter (UGAP) for the quantification of hepatic steatosis in patients with biopsy-proven non-alcoholic fatty liver disease: a prospective study

by | January 19, 2024

  Industry Workshop by GE HealthCare Tommaso Vincenzo Bartolotta, None / Italy In this workshop, Prof Tommaso Bartolotta will share the results of the prospective study conducted at his Institute to validate the accuracy of UGAP, non-invasive technique, to stage liver...